ARTV

Artiva Biotherapeutics, Inc. - Common Stock (ARTV)

About Artiva Biotherapeutics, Inc. - Common Stock (ARTV)

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Details

Daily high

$10.61

Daily low

$10.10

Price at open

$10.49

52 Week High

$14.53

52 Week Low

$2.22

Market cap

499.7M

Dividend yield

Volume

228,438

Avg. volume

283,133

P/E ratio

-3.09

Artiva Biotherapeutics, Inc. - Common Stock News